perioperative management of glp-1 agonists receptor like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) have become incredibly common in diabetes and weight-management care, and they're now showing up more and more in the setting. These π¬π§ Perioperative Management of New
Description
However, individual responses to Tirzepatide can vary based on several factors, including dosage, adherence to the prescribed regimen, lifestyle changes, and individual metabolic differences
You also have side effects
Additionally, these medications enhance insulin secretion in response to meals and suppress glucagon release, improving glycemic control
Stop and contact your doctor immediately if you experience severe abdominal pain, signs of dehydration, vomiting that lasts more than 24 hours, or any symptoms that interfere significantly with daily life
Effect of semaglutide 2.4 mg once weekly on 10-year type 2 diabetes risk in adults with overweight or obesity
